IRIS
ZULIANI, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.726
AS - Asia 2.438
EU - Europa 2.160
SA - Sud America 281
AF - Africa 131
Totale 7.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.648
SG - Singapore 803
CN - Cina 770
VN - Vietnam 410
FI - Finlandia 390
IT - Italia 352
SE - Svezia 284
IE - Irlanda 262
DE - Germania 245
BR - Brasile 221
UA - Ucraina 204
HK - Hong Kong 199
GB - Regno Unito 88
NL - Olanda 84
FR - Francia 78
ZA - Sudafrica 71
RU - Federazione Russa 60
TR - Turchia 58
CA - Canada 55
IN - India 47
BD - Bangladesh 23
CI - Costa d'Avorio 23
BE - Belgio 22
AT - Austria 19
IQ - Iraq 19
JP - Giappone 16
MX - Messico 16
KR - Corea 15
PH - Filippine 15
CZ - Repubblica Ceca 14
AR - Argentina 12
EC - Ecuador 12
ES - Italia 12
PL - Polonia 12
PK - Pakistan 10
LT - Lituania 9
MA - Marocco 9
VE - Venezuela 9
CO - Colombia 8
EG - Egitto 8
ID - Indonesia 8
TH - Thailandia 8
CL - Cile 7
PT - Portogallo 6
KE - Kenya 5
PE - Perù 5
TN - Tunisia 5
IR - Iran 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
PY - Paraguay 3
SA - Arabia Saudita 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
EE - Estonia 2
ET - Etiopia 2
HU - Ungheria 2
JO - Giordania 2
MY - Malesia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
AM - Armenia 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
JM - Giamaica 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
ZW - Zimbabwe 1
Totale 7.736
Salva come PNG Salva come JPEG
Città #
Singapore 419
Ashburn 312
Chandler 279
Dublin 262
San Jose 225
Jacksonville 214
Hong Kong 188
Beijing 183
Santa Clara 152
Dallas 150
Ho Chi Minh City 120
Ann Arbor 119
Dearborn 101
Hanoi 99
Boardman 96
Nanjing 83
Parma 80
Munich 79
Johannesburg 70
Los Angeles 68
New York 63
Hefei 58
Princeton 51
Shanghai 51
Lauterbourg 47
Milan 45
Helsinki 44
Izmir 41
San Mateo 40
Wilmington 35
Toronto 33
Moscow 29
Turku 29
Frankfurt am Main 26
Bremen 25
Shenyang 24
Abidjan 23
Hebei 23
Nanchang 22
Brussels 21
Jinan 21
São Paulo 21
Kunming 19
Vienna 19
Da Nang 18
Buffalo 17
Columbus 17
Seattle 17
London 16
Council Bluffs 15
Guangzhou 15
Tokyo 15
Des Moines 14
Seoul 14
Brooklyn 12
Chennai 12
Jiaxing 12
Phoenix 12
The Dalles 12
Woodbridge 12
Haiphong 11
Ankara 10
Modena 10
Montreal 10
Reggio Emilia 10
Tianjin 10
Bologna 9
Changsha 8
Warsaw 8
Auburn Hills 7
Baghdad 7
Norwalk 7
Nuremberg 7
Orem 7
Pune 7
Amsterdam 6
Atlanta 6
Brno 6
Chengdu 6
Chicago 6
Denver 6
Houston 6
Jakarta 6
Mexico City 6
Piacenza 6
Redondo Beach 6
Belo Horizonte 5
Bengaluru 5
Falkenstein 5
Genoa 5
Guayaquil 5
Haikou 5
Hangzhou 5
Manchester 5
Marseille 5
Poplar 5
Quito 5
Reggio Nell'emilia 5
Stockholm 5
Thái Bình 5
Totale 4.603
Salva come PNG Salva come JPEG
Nome #
2-Aminobenzimidazoles as new potent H3-antagonists 222
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 205
Aminobenzimidazoles as new potent H3-antagonists 194
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 191
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 190
NEW ALKBH2 AND ALKBH5 INHIBITORS FOR TREATING GLIOBLASTOMA 186
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 179
5-benzylidene-hydantoins as new inhibitors of cell proliferation 176
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 175
5-benzylidene-hydantoin UPR 1024 acts as EGFR inhibitor and induces DNA damage in A549 NSCLC cell line 175
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 174
Antiproliferative and proapototic effects of a new combi-molecule on non small cell lung cancer cell lines 174
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 169
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 157
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 157
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 156
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 156
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 154
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 148
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 147
Advances in Design and Development of Sodium Channel Blockers. 145
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 145
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 144
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 144
CNS access of selected H3-antagonists: ex vivo binding study in rats 143
Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines 142
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 139
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 138
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 138
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 136
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 135
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 135
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 131
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 129
Drug repurposing approaches to fight Dengue virus infection and related diseases 127
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 119
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 119
Relationship between structure and ex-vivo binding of imidazole H3 antagonists to rat brain H3 receptors 116
Three-Dimensional Quantitative Structure-Activity Relationship Studies on Selected MT1 and MT2 Melatonin Receptor Ligands: Requirements for Subtype Selectivity and Intrinsic Activity Modulation 115
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 112
NMR Analysis of a Series of Imidazobenzoxazines 110
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 110
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 110
IMIDAZOBENZOXAZIN-5-THIONE (MV1035) TO OVERCOME THE BLOOD-BRAIN BARRIER AND TARGET CNS DISEASES 109
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 108
Structure-Property Relationships on Histamine H3-Antagonists: Binding of Phenyl-substituted Alkylthioimidazole Derivatives to Rat Plasma Proteins 107
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 107
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 103
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 102
Sodium channel blockers: a patent review (2010 - 2014) 101
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 98
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 96
Sodium channel blockers for neuropathic pain. 93
Fluorescent Ligands for the Histamine H2 Receptor: Synthesis and Preliminary Characterization 76
pH-partition profiles of 4-(3-oxo-1,2-benzisothiazolin-2-yl)phenyl and phenoxyalkanoic acids 74
Erratum: Fluorescent ligands for the histamine H 2 receptor: Synthesis and preliminary characterization (Bioorganic & Medicinal Chemistry (2004) 12 (6495-6503)) 65
Recent advances in the discovery of ALKBH 1–8 inhibitors. 61
null 36
Totale 7.803
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.988
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 16 61 5
2021/2022251 2 5 6 20 11 8 33 35 15 18 27 71
2022/20231.103 119 120 83 76 101 143 19 46 322 16 40 18
2023/2024400 14 41 13 11 39 96 40 23 17 23 31 52
2024/20251.386 56 83 101 115 67 143 52 84 108 131 151 295
2025/20262.933 270 327 357 330 404 200 364 84 371 226 0 0
Totale 7.803